N-3 Fatty Acids for the Prevention of Atrial Fibrillation in Patients With Acute Heart Failure
1 other identifier
interventional
160
0 countries
N/A
Brief Summary
Our study is to investigate the effect of N-3 Fatty Acids for the prevention of atrial fibrillation in patients with acute heart failure or acute myocardial infarction
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for phase_4
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
May 29, 2008
CompletedFirst Posted
Study publicly available on registry
June 6, 2008
CompletedStudy Start
First participant enrolled
July 1, 2008
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 1, 2010
CompletedJune 19, 2008
June 1, 2008
1.9 years
May 29, 2008
June 18, 2008
Conditions
Outcome Measures
Primary Outcomes (1)
detection of atrial fibrillation on ECG monitoring
anytime during hospitalization
Interventions
Epadel 900mg, 2 times a day, during hospitalization
Eligibility Criteria
You may qualify if:
- sinus rhythm patients with acute heart failure or acute myocardial infarction
You may not qualify if:
- pregnancy,allergy to epadel
Contact the study team to confirm eligibility.
Sponsors & Collaborators
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- phase 4
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
Study Record Dates
First Submitted
May 29, 2008
First Posted
June 6, 2008
Study Start
July 1, 2008
Primary Completion
June 1, 2010
Last Updated
June 19, 2008
Record last verified: 2008-06